As the summer days pass, I'm getting anxious for the P results....knowing that many companies have tried and failed to find decent therapies for psoriasis with only a few showing moderate success (and a lot of nasty side effects) if Menon's brilliance could somehow result in another oral drug with even minimal success, it could be absolutely huge. I have been invested in small bios in the past where it looked promising and ended up getting junk results, so I recognize nothing is certain with these indications and especially in the case of psoriasis. That all being said, I also recognize that B-OM is set to be licensed and will likely carry the day, but I have had a gut feeling about P since the early days when I first invested in CTIX/IPIX. Either way, these next 10 weeks are going to be very interesting....
(4)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links